← Back to All Filings

Zoetis (ZTS) EVP Awarded Phantom Stock Units Valued at $7.4k

Low SignificanceOctober 14, 2025 at 4:36:36 PM EDT

Zoetis Inc.

$ZTS4CIK: 0001555280

Subscribe to track ZTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Zoetis (ZTS) EVP Awarded Phantom Stock Units Valued at $7.4k

Company: Zoetis Inc. (ZTS) Form: 4 | Filed: 2025-10-14 Significance: Low

Insider: Sarbaugh Keith Title: Executive Vice President | Relationship: Officer

Transaction: • Type: Award • Shares: 158.51 • Price: $46.71 • Value: $7,404 • Owned After: 1,098.16 (Phantom Stock Units)

Key Insight: This is a routine, low-value award of phantom stock units as part of the Zoetis Supplemental Savings Plan, indicating standard executive compensation rather than a direct market purchase.

Market Context: Such awards are common for executives and typically do not signal new insider sentiment or have a material impact on the stock price.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Zoetis Inc. (ZTS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An Executive Vice President at Zoetis received a routine, low-value award of phantom stock units as part of a company savings plan. This is a standard compensation event, not an open-market transaction, and carries minimal trading significance.
  • Market Impact: Neutral. This type of filing is common and is not expected to influence the stock's price or trading volume.

Company Information

FieldValue
CompanyZoetis Inc.
Ticker SymbolZTS
CIK0001555280
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameSarbaugh Keith
CIK0002044651
Title/PositionExecutive Vice President
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-10
Transaction CodeA (Award)
Security TypePhantom Stock Unit
Shares Involved158.5078
Price Per Share$46.71
Total Value$7,403.79
Shares Owned After1098.1566
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is an award, not an open-market purchase or sale. The value is nominal for an executive-level position, representing standard compensation rather than a strategic investment decision by the insider.

Volume & Sentiment

  • Expected Volume Impact: Negligible. Compensation-related awards do not typically affect trading volume.
  • Sentiment Indicator: Neutral. The filing does not provide any new bullish or bearish signals.

Investment Insights

Positive Market Indicators

  • None. This filing is a routine administrative event related to executive compensation.

Risk Factors

  • None. No risks are indicated by this transaction.

Key Takeaways

  1. Routine Compensation: The transaction is an award of phantom stock units acquired under the Zoetis Supplemental Savings Plan.
  2. Not an Open-Market Trade: This was not a purchase of shares on the open market, so it does not reflect the insider's direct sentiment on the stock's current valuation.
  3. Cash-Settled Derivative: The phantom stock units are derivative securities that are settled in cash upon the reporting person's separation from service, as noted in the filing's footnotes.

Contextual Analysis

Timing Significance

  • The timing of the award does not appear to be significant and is likely tied to a regular schedule within the company's compensation or savings plan.

Transaction Context

  • The filing's footnotes clarify that these phantom stock units were acquired via the 'Zoetis Supplemental Savings Plan'. They are settled in cash and their value is tied to Zoetis common stock. This confirms the nature of the transaction as part of a structured compensation/savings vehicle.

Company Context

  • This filing should be viewed in the broader context of Zoetis's overall financial health, recent earnings reports, and industry trends. As a standalone event, it provides no new information about the company's operational performance or strategic direction.

Risk Assessment

Risk Level: Low

Risk Factors

  • This filing itself presents no discernible risk factors to the company or its stock.

Market Considerations

  • Investors should focus on fundamental analysis, industry news, and macroeconomic factors rather than drawing conclusions from this routine compensation filing.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#ZTS#Zoetis#Form4#InsiderAward#StockMarket#Investing#LowSignificance#ExecutiveComp

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.